CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

CorMedix (Nasdaq: CRMD), a biopharmaceutical company specializing in therapeutic products for life-threatening diseases, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The event will be held virtually from April 7-10, 2025.

The company's management will engage in a Fireside Chat scheduled for Tuesday, April 8, 2025, at 2:15 p.m. EDT. This participation aligns with CorMedix's ongoing efforts to maintain investor relations and industry presence.

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in the 24^th Annual Needham Virtual Healthcare Conference, taking place virtually on April 7-10, 2025.

24^th Annual Needham Virtual Healthcare Conference

Date:	Tuesday, April 8, 2025
Time:	2:15p.m. EDT
Format:	Fireside Chat
Webcast:	Link

About CorMedix

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath^® (taurolidine and heparin) which was approved by the FDA on November 15, 2023. CorMedix commercially launched DefenCath in inpatient settings in April 2024 and in outpatient settings in July 2024. CorMedix is commencing clinical studies in adult Total Parenteral Nutrition (TPN) patients and pediatric hemodialysis (HD) patient populations in 2025 and also intends to develop DefenCath as a catheter lock solution for use in other therapeutic areas. For more information visit: www.cormedix.com.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576

FAQ

When is CorMedix (CRMD) presenting at the Needham Healthcare Conference 2025?

CorMedix (CRMD) is scheduled to present on Tuesday, April 8, 2025, at 2:15 p.m. EDT during the 24th Annual Needham Virtual Healthcare Conference.

What type of presentation format will CRMD use at the Needham Conference 2025?

CRMD will participate in a Fireside Chat format presentation at the conference.

What are the dates for the 24th Annual Needham Virtual Healthcare Conference?

The 24th Annual Needham Virtual Healthcare Conference will take place virtually from April 7-10, 2025.

What is the main focus of CorMedix (CRMD) as a company?

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions.